Tissue microarray analysis of cytoskeletal actin-associated biomarkers Gelsolin and E-cadherin in urothelial carcinoma

Cancer

Volumn 95, Issue 6, 2002, Pages 1247-1257

  Rao, Jian Yu ^a,b   Seligson, David ^a,b   Visapaa, Harri ^a,b   Horvath, Steve ^a,b   Eeva, Mervi ^b   Michel, Kia ^a   Pantuck, Allan ^a   Belldegrun, Arie ^a   Palotie, Aarno ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

E cadherin; Gelsolin; Pre maligant and malignant lesions; Tissue microarrays; Urothelial carcinoma

Indexed keywords

ACTIN; BIOLOGICAL MARKER; GELSOLIN; KI 67 ANTIGEN; PROTEIN P53; UVOMORULIN;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BLADDER CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER STAGING; CARCINOGENESIS; CARCINOMA IN SITU; CONTROLLED STUDY; CYTOSKELETON; DNA MICROARRAY; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR RECURRENCE; UROGENITAL TRACT TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, TRANSITIONAL CELL; FEMALE; GELSOLIN; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 0037105470     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10823     Document Type: Article

References (40)

1. Cell growth dynamics in long-term bladder carcinogenesis
2. Molecular pathology and bio-markers of bladder cancer
3. Cytology of bladder cancer
4. Transitional cell neo-plasms of the urinary bladder: Can biological potential be predicted from histologic grading?
5. Cellular actin levels as a marker for cellular transformation: Relationship to cell division and differentiation
6. Cellular F-actin levels as a marker for cellular transformation: II Correlation with bladder cancer risk
7. Alterations in phenotypic biochemical markers in bladder epithelium during tumori-genesis
8. Alterations of the actin polymerization status as an apoptotic morphological effector in HL-60 cells
9. Biomarkers in monitoring the effectiveness of chemopreventive and immunotherapeutic treatments of bladder cancer
10. Functions of Gelsolin: Motility, signaling, apoptosis, cancer
11. Dissecting tumor cell invasion: Epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion
12. Gelsolin: A candidate for suppressor of human bladder cancer
13. Caspase-3 generated fragment of Gelsolin: Effector of morphological change in apoptosis
14. Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals
15. E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder
16. Prognostic value of E-cadherin, beta-catenin, P120ctn in patients with transitional cell bladder cancer
17. Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information
18. Tissue microarrays for high-throughput molecular profiling of tumor specimens
19. Actin and actin-binding proteins. A critical evaluation of mechanisms and functions
20. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1
21. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia
22. Cytoskeletal ups and downs
23. Intercellular communication and cell-cell adhesion
24. Suppression of tumorigenicity in transformed cells after transfection with Vinculin cDNA
25. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role
26. Gelsolin: A candidate for suppressor of human bladder cancer
27. Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene
28. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer
29. Survey of gene amplifications during bladder cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays
30. Multiple tissue core arrays in histopathology research: A validation study
31. Validation of tissue microarray technology in breast carcinoma
32. Widespread loss of Gelsolin in breast cancers of humans, mice, and rats
33. Gelsolin gene therapy by retrovirus producer cells for human bladder cancer in nude mice
34. Motility as a prognostic factor in non-small cell lung cancer: Role of Gelsolin expression
35. Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers
36. Pathology and staging of bladder cancer
37. Ta and T1 bladder cancer: Location, recurrence and progression
38. Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors
39. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder